Literature DB >> 19269061

Effects of aging, Parkinson's disease, and dopaminergic medication on response selection and control.

Rita Willemssen1, Michael Falkenstein, Michael Schwarz, Thomas Müller, Christian Beste.   

Abstract

We examined effects of short-term and long-term dopaminergic medication in Parkinson's disease on conflict monitoring or response selection processes. These processes were examined using event-related potentials (ERPs), while subjects performed a stimulus-response (S-R) compatibility task. An extended sample of young and elderly controls, Parkinson's disease patients with a medication history (PDs) and initially diagnosed, drug-naïve de novo PD patients (de novo PDs) were enrolled. Both PD groups were measured twice (on and off-medication or before and 8 weeks after medication onset). The results show that dopaminergic intervention selectively reduced the pathologically enhanced response selection in compatible S-R relations. This medication effect was already evident after short-term treatment, not differing from long-term treatment and performance in elderly controls. Contrary, age-related attenuations of the N2 in incompatible S-R relations, probably reflecting impaired conflict processing or response control, are unaffected by medication. The results suggest that compatible and incompatible S-R relations demand different neuronal mechanisms within the basal ganglia, as only the former are affected by agonizing the dopaminergic system.
Copyright © 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19269061     DOI: 10.1016/j.neurobiolaging.2009.02.002

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  22 in total

1.  Mechanisms underlying age- and performance-related differences in working memory.

Authors:  Kirk R Daffner; Hyemi Chong; Xue Sun; Elise C Tarbi; Jenna L Riis; Scott M McGinnis; Phillip J Holcomb
Journal:  J Cogn Neurosci       Date:  2010-07-09       Impact factor: 3.225

2.  Striatal GABA-MRS predicts response inhibition performance and its cortical electrophysiological correlates.

Authors:  Clara Quetscher; Ali Yildiz; Shalmali Dharmadhikari; Benjamin Glaubitz; Tobias Schmidt-Wilcke; Ulrike Dydak; Christian Beste
Journal:  Brain Struct Funct       Date:  2014-08-26       Impact factor: 3.270

Review 3.  The neurobehavioral impact of manganese: results and challenges obtained by a meta-analysis of individual participant data.

Authors:  Monika Meyer-Baron; Michael Schäper; Guido Knapp; Roberto Lucchini; Silvia Zoni; Rita Bast-Pettersen; Dag G Ellingsen; Yngvar Thomassen; Shuchang He; Hong Yuan; Qiao Niu; Xian-Liang Wang; Yong-Jian Yang; Anders Iregren; Bengt Sjögren; Morten Blond; Peter Laursen; Bo Netterstrom; Donna Mergler; Rosemarie Bowler; Christoph van Thriel
Journal:  Neurotoxicology       Date:  2013-02-16       Impact factor: 4.294

4.  Striatal and thalamic GABA level concentrations play differential roles for the modulation of response selection processes by proprioceptive information.

Authors:  Shalmali Dharmadhikari; Ruoyun Ma; Chien-Lin Yeh; Ann-Kathrin Stock; Sandy Snyder; S Elizabeth Zauber; Ulrike Dydak; Christian Beste
Journal:  Neuroimage       Date:  2015-06-30       Impact factor: 6.556

5.  Interrelation of resting state functional connectivity, striatal GABA levels, and cognitive control processes.

Authors:  Lauren Haag; Clara Quetscher; Shalmali Dharmadhikari; Ulrike Dydak; Tobias Schmidt-Wilcke; Christian Beste
Journal:  Hum Brain Mapp       Date:  2015-09-10       Impact factor: 5.038

6.  Age-related differences in early novelty processing: using PCA to parse the overlapping anterior P2 and N2 components.

Authors:  Kirk R Daffner; Brittany R Alperin; Katherine K Mott; Erich S Tusch; Phillip J Holcomb
Journal:  Biol Psychol       Date:  2015-01-14       Impact factor: 3.251

7.  The aging brain shows less flexible reallocation of cognitive resources during dual-task walking: A mobile brain/body imaging (MoBI) study.

Authors:  Brenda R Malcolm; John J Foxe; John S Butler; Pierfilippo De Sanctis
Journal:  Neuroimage       Date:  2015-05-16       Impact factor: 6.556

8.  The late positive potential, emotion and apathy in Parkinson's disease.

Authors:  J Dietz; M M Bradley; J Jones; M S Okun; W M Perlstein; D Bowers
Journal:  Neuropsychologia       Date:  2013-01-12       Impact factor: 3.139

9.  A novel cognitive-neurophysiological state biomarker in premanifest Huntington's disease validated on longitudinal data.

Authors:  Christian Beste; Ann-Kathrin Stock; Vanessa Ness; Rainer Hoffmann; Carsten Lukas; Carsten Saft
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

10.  The effects of aging on conflict detection.

Authors:  Giuliana Lucci; Marika Berchicci; Donatella Spinelli; Francesco Taddei; Francesco Di Russo
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.